Skip to content

Public FDA record

Z-1898-2020: NUVASIVE MAGEC 2 Rod X.X mm XX mm, REF MC2-XXXXS LOT 0000000 AAA - Product Usage: comprised of a steril

Recall record Z-1898-2020 for NuVasive Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1898-2020
Company in FDA record
NuVasive Inc
FDA record creation date
May 5, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Post-implantation separation of an actuator end cap component that may expose internal components of the actuator, which could lead to hastened degeneration of the internal components and egress of Titanium alloy wear debris and resultant localized tissue discoloration.

Source facts

Action
The Recalling Firm sent an "URGENT FIELD SAFETY NOTICE" to customers via email and/or FedEx informing them that Post-implantation separation of an actuator end cap component has been observed and that separation of the end cap may expose internal components of the actuator, which could lead to hastened degeneration of the internal components and egress of Titanium alloy wear debris and resultant localized tissue discoloration. The firm also informed customers that the long-term ability of a rod with a separated actuator end cap to continue to lengthen/distract is currently unknown. Distributors were contacted via email on 2/17/2020 Surgeons US were contacted via email and/or FedEx between 2/14/2020 to 2/18/2020. Surgeons OUS were contacted via email between 2/17/2020 to 2/21/2020. The Recalling Firm is recommending that surgeons perform routine clinical follow-up and discuss potential clinical implications and risks with patients who received affected products. The Recalling Firm is not recommending prophylactic revision based solely on the separation of an end cap. However, if an end cap separation is detected, removal of the device may be indicated. The decision to remove the device should be made by the physician in consultation with the patient and/or family. The Recalling Firm's Recommended User Action: -Immediately examine inventory to determine if they have product subject to this action on hand and quarantine the product. The Recalling Firm's representative will visit offices or contact customers directly to provide instructions for the return of the affected products. -Review, complete, sign and return the attached Consignee Confirmation Form accompanying the notification in accordance with the directions on the form. -Do not implant rods until further notice. -Review the details below and understand how to identify a separated end cap on postoperative XRay imaging: -Users should follow the appropriate postoperative procedure to assess the
Initiated
2020-02-13
Root cause
Process control
Terminated
2022-05-25
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, and WV. The Countries of Argentina, Austria, Belgium, Bulgaria, Canada, Chile, Denmark, Finland, France, Germany, Hong Kong, Hungary, India, Israel, Ireland, Italy, Jordan, Kuwait, Luxembourg, Malaysia, Netherlands, Norway, Philippines, Poland, Portugal, Saudi Arabia, Slovenia/Serbia, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, and United Kingdom.
Recall number
Z-1898-2020
Recall status
Terminated
CDRH record ID
181098
FDA record created
2020-05-05
Recall event number
85495

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗